CRISPR-Cas9-mediated IncF plasmid curing in extraintestinal pathogenic Escherichia coli
Microbiology Spectrum · 11.01.2024 · 12 (1)
DOI: 10.1128/spectrum.03692-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 11.01.2024. Verfasst von Liang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack-Meridian Health , Nutley, New Jersey, USA. Hauptthemen laut MEDLINE: Extraintestinal Pathogenic Escherichia coli, Escherichia coli Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIAAA NIH HHS, HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
IncF plasmids are commonly found in extra-intestinal pathogenic Escherichia coli (ExPEC) strains, serving as reservoirs for antimicrobial resistance (AMR) genes and virulence factors, persistently coexisting with ExPEC lineages. Multidrug-resistant (MDR) high-risk ExPEC clones, particularly ST131, ST1193, and ST410, have acquired diverse IncF plasmids over time, containing various AMR determinants, contributing significantly to their global success. However, the broader roles of these IncF plasmids in the success of MDR ExPEC clones, beyond AMR, remain elusive. In this study, we employed a novel clustered regularly interspaced short palindromic repeats–CRISPR-associated protein-9 nuclease (CRISPR-Cas9)-mediated pCasCure plasmid-curing system to precisely remove specific IncF plasmids among ExPEC clones (ST1193, ST131, and ST410). Antibiotic-resistant parent strains reverted to antibiotic-susceptible states post-curing; however, IncF plasmid curing did not show significant impact on bacterial in vitro growth and had little impact on other in vitro phenotypes, including survival in water, dry environment and biofilm production. In addition, IncF plasmid curing did not affect the conjugation frequency of KPC-producing pKpQIL plasmid. This study represents a pivotal initial step in understanding the precise roles of IncF plasmids in the success of ExPEC. Future research will be crucial in investigating their influence on cell invasion and in vivo fitness, thereby providing a more comprehensive perspective on the functions of IncF plasmids in MDR ExPEC clones. IMPORTANCE Understanding the role of IncF plasmids in the success of drug-resistant bacteria has far-reaching implications for tackling antibiotic resistance. The study's use of a novel CRISPR-Cas9-mediated plasmid-curing system provides a precision tool for dissecting the specific impact of IncF plasmids on ExPEC clones, especially high-risk, multidrug-resistant strains like ST131, ST1193, and ST410. The study offers a crucial stepping stone for future research into understanding how these plasmids influence more complex aspects of bacterial behavior, such as cell invasion and in vivo fitness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Discovery and Innovation, Hackensack-Meridian Health , Nutley, New Jersey, USA.
- Hackensack Meridian School of Medicine , Nutley, New Jersey, USA.
- Cummings School of Medicine, University of Calgary , Calgary, Alberta, Canada.
- Alberta Precision Laboratories , Calgary, Alberta, Canada.
- Department of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine , Shanghai, China.
- University of Pretoria , Pretoria, Gauteng, South Africa.
ORCID-Profile: Liang Chen, Barry N Kreiswirth
Förderung
- NIAID NIH HHS
- NIAAA NIH HHS
- HHS | NIH | NIAID | Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Gouvernement du Canada | Canadian Institutes of Health Research
Zitieren
APA
Chen, L., Peirano, G., Yen, K., Wang, B., Terlecky, A., DeVinney, R., Kreiswirth, B. N., & Pitout, J. D. D. (2024). CRISPR-Cas9-mediated IncF plasmid curing in extraintestinal pathogenic Escherichia coli. Microbiology Spectrum, 12(1). https://doi.org/10.1128/spectrum.03692-23
Vancouver
Chen L, Peirano G, Yen K, Wang B, Terlecky A, DeVinney R, et al. CRISPR-Cas9-mediated IncF plasmid curing in extraintestinal pathogenic Escherichia coli. Microbiology Spectrum. 2024;12(1). doi:10.1128/spectrum.03692-23
BibTeX
@article{Chen2024,
author = {Chen, Liang and Peirano, Gisele and Yen, Kelly and Wang, Bingjie and Terlecky, Austin and DeVinney, Rebekah and Kreiswirth, Barry N and Pitout, Johann D D},
title = {CRISPR-Cas9-mediated IncF plasmid curing in extraintestinal pathogenic Escherichia coli},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {1},
doi = {10.1128/spectrum.03692-23}
}
EUVIMED